SARS-CoV-2 S protein (944-1214 aa) Polyklonaler Antikörper

SARS-CoV-2 S protein (944-1214 aa) Polyklonal Antikörper für ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Virus und mehr (3)

Anwendung

WB, IF, ELISA

Konjugation

Unkonjugiert

Publikationen(10)

Kat-Nr. : 28867-1-AP

Synonyme

RBD, COVID-19 RBD, Spike, spike protein, SARS-CoV-2 Spike



Geprüfte Anwendungen

Erfolgreiche Detektion in ELISARecombinant protein

Empfohlene Verdünnung

AnwendungVerdünnung
Enzyme-linked Immunosorbent Assay (ELISA)ELISA :
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

WBSee 2 publications below
IFSee 8 publications below

Produktinformation

28867-1-AP bindet in WB, IF, ELISA SARS-CoV-2 S protein (944-1214 aa) und zeigt Reaktivität mit Virus

Getestete Reaktivität Virus
In Publikationen genannte Reaktivitäthuman, Affe, hamster
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen SARS-CoV-2 S protein (944-1214 aa) fusion protein Ag30685
Vollständiger Name SARS-CoV-2 Spike Protein
Berechnetes Molekulargewicht 141 kDa
GenBank-ZugangsnummerNC_045512
Gene symbol SARS-COV-2
Gene ID (NCBI) 43740568
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS with 0.02% sodium azide and 50% glycerol
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Coronaviruses (CoVs) infect human and animals and cause varieties of diseases, including respiratory, enteric, renal, and neurological diseases. CoV uses its spike protein to recognize ACE2 as its receptors and mediate membrane fusion and virus entry into host cells(PMID: 32221306). Each monomer of trimeric S protein is about 180 kDa, and contains two subunits, S1 and S2,S1 recognizes and binds to host receptors, and subsequent conformational changes in S2 facilitate fusion between the viral envelope and the host cell membrane(PMID: 19198616). Although the amino acid sequences of the S-glycoprotein were found to be different between the various HCoV, the structures showed high similarity, but the best 3D structural overlap shared by SARS-CoV and SARS-CoV-2, consistent with the shared ACE2 predicted receptor (PMID: 32522207). The spike protein of CoVs can be a target for vaccine and therapeutic development (PMID: 19198616). This antibody detects the spike protein of SARS and SARS-COV-2.

Publikationen

SpeciesApplicationTitle
monkey,hamsterIF

Nat Biomed Eng

High-throughput screening of genetic and cellular drivers of syncytium formation induced by the spike protein of SARS-CoV-2

Authors - Charles W F Chan
humanIF

Nat Immunol

Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules.

Authors - Matteo Stravalaci
humanIF

Nat Commun

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways

Authors - Naoko Iwata-Yoshikawa
WB

bioRxiv

Ubiquitin Ligase ITCH Regulates Life Cycle of SARS-CoV-2 Virus

Authors - Qiwang Xiang
IF

Cell Rep

Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2.

Authors - Xiaojuan Zhou
humanIF

J Virol

The respective roles of TMPRSS2 and cathepsins for SARS-CoV-2 infection in human respiratory organoids

Authors - Masatoshi Kakizaki